Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo

References

• Skolnik A, Gan TJ. New formulations of bupivacaine for the treatment of postoperative pain: liposomal bupivacaine and SABER-Bupivacaine. Expert Opin Pharmacother 2014;15:1535–42.
   PubMed Web of Science ®Google Scholar
• Cheng TL, Valtchev P, Murphy CM, et al. A sugar-based phase-transitioning delivery system for bone tissue engineering. Eur Cell Mater 2013;26:208–21.
   PubMed Web of Science ®Google Scholar
• Jolck RI, Binderup T, Hansen AE, et al. Injectable colloidal gold in a sucrose acetate isobutyrate gelating matrix with potential use in radiation therapy. Adv Healthc Mater 2014;3:1680–7.
   PubMed Web of Science ®Google Scholar
• Gao Z, Ding P, Zhang L, et al. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels. Int J Pharm 2007;328:57–64.
   PubMed Web of Science ®Google Scholar
• Shi X, Lin X, Yao C, et al. Injectable long-acting in situ forming systems for Radix Ophiopogonis polysaccharide. Int J Biol Macromol 2015;72:553–9.
   PubMed Web of Science ®Google Scholar
• Kraeling RR, Barb CR, Rampacek GB. Luteinizing hormone response to controlled-release deslorelin in estradiol benzoate primed ovariectomized gilts. Theriogenology 2000;53:1681–9.
   PubMed Web of Science ®Google Scholar
• Okumu FW, Daole N, Fielder PJ, et al. Sustained delivery of human growth hormone from a novel gel system: SABER. Biomaterials 2002;23:4353–8.
   PubMed Web of Science ®Google Scholar
• Pechenov S, Shenoy B, Yang MX, et al. Injectable controlled release formulations incorporating protein crystals. J Control Release 2004;96:149–58.
   PubMed Web of Science ®Google Scholar
• Kempe S, Mader K. In situ forming implants – an attractive formulation principle for parenteral depot formulations. J Control Release 2012;161:668–79.
   PubMed Web of Science ®Google Scholar
• Lu YX, Yu YL, Tang X. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. J Pharm Sci 2007;96:3252–62.
   PubMed Web of Science ®Google Scholar
• Lin X, Yang S, Gou J, et al. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. J Mater Sci Mater Med 2012;23:443–55.
   PubMed Web of Science ®Google Scholar
• Lu YX, Tang X, Cui Y, et al. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Eur J Pharm Biopharm 2008;68:422–9.
   PubMed Web of Science ®Google Scholar
• Lin X, Xu Y, Tang X, et al. A uniform ultra-small microsphere/SAIB hybrid depot with low burst release for long-term continuous drug release. Pharm Res 2015;32:3708–21.
   PubMed Web of Science ®Google Scholar
• Okumu FW, Darling S, Daole N. SABER™ provides burst free release of growth hormone from PLGA microspheres. San Francisco: Millennial World Congress of Pharmaceutical Sciences; 2000.
   Google Scholar
• Dang QF, Liu CS, Wang YJ, et al. Characterization and biocompatibility of injectable microspheres-loaded hydrogel for methotrexate delivery. Carbohydr Polym Polym 2016;136:516–26.
   PubMed Web of Science ®Google Scholar
• Wang JW, Xu JH, Li J, et al. Improvement of the antitumor efficacy of intratumoral administration of cucurbitacin poly(lactic-co-glycolic acid) microspheres incorporated in in situ -forming sucrose acetate isobutyrate depots. J Pharm Sci 2015. [Epub ahead of print]. DOI: 10.1002/jps.24695.
   Google Scholar
• Posadowska U, Parizek M, Filova E, et al. Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate. Int J Pharm 2015;485:31–40.
   PubMed Web of Science ®Google Scholar
• Ozeki T, Kaneko D, Hashizawa K, et al. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel. Int J Pharm 2012;430:393.
   Web of Science ®Google Scholar
• Berchane NS, Jebrail FF, Andrews MJ. Optimization of PLG microspheres for tailored drug release. Int J Pharm 2010;383:81–8.
   PubMed Web of Science ®Google Scholar
• Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory. Int J Pharm 2007;337:118–26.
   PubMed Web of Science ®Google Scholar
• Xia YJ, Pack DW. Uniform biodegradable microparticle systems for controlled release. Chem Eng Sci 2015;125:129–43.
   Web of Science ®Google Scholar
• Jiang T, Petersen RR, Call G, et al. Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis. J Biomed Mater Res Part B: Appl Biomater Biomed Res Appl 2011;97:355–63.
   PubMed Web of Science ®Google Scholar
• Berkland C, Kipper MJ, Narasimhan B, et al. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release 2004;94:129–41.
   PubMed Web of Science ®Google Scholar
• Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors. Pharm Res 2003;20:1055–62.
   PubMed Web of Science ®Google Scholar
• Ereshefsky L, Mannaert E. Pharmacokinetic profile and clinical efficacy of long-acting risperidone: potential benefits of combining an atypical antipsychotic and a new delivery system. Drugs R D 2005;6:129–37.
   PubMedGoogle Scholar
• Eerdekens M, Van Hove I, Remmerie B, Mannaert E. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res 2004;70:91–100.
   PubMed Web of Science ®Google Scholar
• Gupta V, Davis M, Hope-Weeks LJ, Ahsan F. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-beta-cyclodextrin (PGE1-HPbetaCD) complex for the treatment of pulmonary arterial hypertension (PAH). Pharm Res 2011;28:1733–49.
   PubMed Web of Science ®Google Scholar
• Endler M, Endler R, Bobertz B, et al. Linkage between acoustic parameters and seabed sediment properties in the south-western Baltic Sea. Geo-Mar Lett 2015;35:145–60.
   Web of Science ®Google Scholar
• Tibor K, Simon T. Grapho-analytical calculation of particle size distribution characteristics of concrete aggregates. 2006. Available from: http://www.betonopus.hu/some/grapho-analytical.pdf.
   Google Scholar
• Cepuritis R, Wigum BJ, Garboczi EJ, et al. Filler from crushed aggregate for concrete: pore structure, specific surface, particle shape and size distribution. Cement Concrete Comp 2014;54:2–16.
   Web of Science ®Google Scholar
• Brodbeck KJ, DesNoyer JR, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 1999;62:333–44.
   PubMed Web of Science ®Google Scholar
• Graham PD, Brodbeck KJ, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 1999;58:233–45.
   PubMed Web of Science ®Google Scholar
• Luan X, Bodmeier R. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles. Eur J Pharm Biopharm 2006;63:205–14.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW, Bodmeier R, McGinity JW. Solvent selection in the preparation of poly (dl -lactide) microspheres prepared by the solvent evaporation method. Int J Pharm 1988;43:179–86.
   Web of Science ®Google Scholar
• Rawat A, Majumder QH, Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J Control Release 2008;128:224–32.
   PubMed Web of Science ®Google Scholar
• Liu H, Shi S, Cao J, et al. Preparation and evaluation of a novel bioactive glass/lysozyme/PLGA composite microsphere. Drug Dev Ind Pharm 2015;41:458–63.
   PubMed Web of Science ®Google Scholar
• Thote AJ, Chappell JT Jr, Gupta RB, Kumar R. Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs. Drug Dev Ind Pharm 2005;31:43–57.
   PubMed Web of Science ®Google Scholar
• Thomas C, Gupta V, Ahsan F. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. Pharm Res 2010;27:905–19.
   PubMed Web of Science ®Google Scholar
• Tran VT, Benoît JP, Venier-Julienne MC. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm 2011;407:1–11.
   PubMed Web of Science ®Google Scholar
• Liu C, Kong C, Wu G, et al. Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization. Int J Pharm 2015;495:500–7.
   PubMed Web of Science ®Google Scholar